Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 March 2024 | Story VALENTINO NDABA | Photo SUPPLIED
Prof Geo Quinot and with Ntando Ncamane
Prof Geo Quinot from Stellenbosch University, pictured with Ntando Ncamane, a Lecturer in the UFS Department of Mercantile Law.

The Department of Mercantile Law at the University of the Free State (UFS) recently spearheaded a Legal Education Colloquium, marking the genesis of a groundbreaking book project with the vision of revitalising legal education across South Africa. Attended by luminaries from academia, legal practitioners, and students, the event featured Professor Geo Quinot from Stellenbosch University, a distinguished figure renowned for his profound insights into legal education, as the keynote speaker.

Ntando Ncamane, a Lecturer in Mercantile Law, provided a comprehensive overview of the colloquium’s objectives, outcomes, and future trajectory. "The dynamic evolution of legal frameworks, notably the promulgation of the Constitution, statutes, and landmark cases, has necessitated a reformation in South African legal education,"  Ncamane remarked. He underscored the pivotal role of digital transformation, particularly in the context of the pandemic, and emphasised the joint commitment of regulatory bodies and academic institutions towards fostering an ethos of engaged scholarship. The colloquium served as a platform to dissect and explore transformative trends, inviting stakeholders to deliberate on novel perspectives and navigate emerging challenges in legal education.

Insights from Prof Geo Quinot and eminent experts

Reflecting on the invaluable insights garnered from deliberations, Ncamane highlighted Professor Quinot's keynote address, which advocated for a reimagining of collaborative endeavours, particularly involving students. Discussions spanned an array of topics including innovative methodologies, enhancing assessment frameworks, leveraging digital platforms for education, integrating competition law into curricula, promoting engaged scholarship, nurturing emotional intelligence among students, and addressing complexities within modules such as civil procedure. Stimulating dialogues on decoloniality, decolonisation, and ubuntu ethos also permeated the discourse. 

The forthcoming book, a culmination of the colloquium, will traverse themes encompassing Digital Education, Student Engagement, and Decolonisation. Ncamane elucidated, "Contributors will be aligned with one of the themes based on the relevance of their contributions…A call for papers was issued, eliciting abstract submissions from prospective contributors."

Scholars hailing from diverse academic institutions including the UFS, University of the Witwatersrand, University of Limpopo, University of Fort Hare, North-West University, Varsity College, and Stellenbosch University, have been enlisted for participation. Each chapter will undergo a peer review process, ensuring scholarly rigour and academic excellence. 

Role and impact of the book

Articulating the envisioned role of the book, Ncamane underscored its potential to reshape legal education and curriculum development. He said, "The book offers key approaches that can be adopted by legal scholars to improve teaching methods, ultimately benefiting students, academics, and society at large."

With regards to timelines, Ncamane indicated that the publication is slated for release in late 2024 or early 2025, contingent upon the duration of the blind review process and editorial refinement. The Legal Education Colloquium and its ensuing book project exemplify a concerted endeavour to address the evolving imperatives of legal education, foster scholarly discourse, and contribute meaningfully to the enhancement of legal praxis in South Africa.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept